로딩 중…
지수 로딩 중…
NovoCure Limited
NVCR· NASDAQ· Health Care· Health Care Equipment & Services
JE
$15.32+3.23%
2026-08-03
Financials
Valuation Metrics
NovoCure Limited's Market Cap is $1.77B. At end of 2025 it was $1.44B. Ranked #2149 of 3,111 in US market (top 69%), #840 of 1,445 on NASDAQ (top 58%), #126 of 206 in Health Care Equipment & Services (top 61%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.77B | US#2,149/3,111 Sec#126/206 |
| Revenue | $699M | US#2,175/3,111 Sec#134/206 |
| Net Income | $-149M | US—/3,111 Sec—/206 |
| Total Assets | $795M | US#2,551/3,111 Sec#138/206 |
| Net Assets | $338M | US#2,496/3,111 Sec#143/206 |
| Value | ||
| P/B | 5.25x | US#2,208/3,111 Sec#143/206 |
| P/S | 2.54x | US#1,509/3,111 Sec#108/206 |
| FCF Yield | -1.20% | US—/3,111 Sec—/206 |
| Profitability | ||
| ROE | -43.94% | US#2,718/3,111 Sec#172/206 |
| ROA | -18.68% | US#2,770/3,111 Sec#172/206 |
| Op. Margin | -22.08% | US#2,711/3,111 Sec#172/206 |
| Revenue Growth | 15.60% | US#943/3,111 Sec#61/206 |
| Financial Health | ||
| Debt Ratio | 135.20% | US#1,387/3,111 Sec#131/206 |
| Total Debt | $233M | US#2,159/3,111 Sec#116/206 |
| FCF | $-21M | US#2,385/3,111 Sec#164/206 |
| Cash | $94M | US#2,261/3,111 Sec#146/206 |
| Current Ratio | 2.89x | US#843/3,111 Sec#89/206 |
| Performance | ||
| 1Y Return | 35.34% | US#1,211/3,111 Sec#76/206 |
| 1M Return | -10.93% | US#2,217/3,111 Sec#142/206 |
| From 52W High | -28.58% | US#2,139/3,111 Sec#144/206 |
| 1Y MDD | -48.30% | US#2,343/3,111 Sec#140/206 |
| Trading | ||
| Volume | 1,612,317 shares | US#1,273/3,111 Sec#76/206 |
| Trading Value | $25M | US#1,987/3,111 Sec#132/206 |
| Per Share | ||
| EPS | $-1.22 | US—/3,111 Sec—/206 |
| BPS | $3.05 | US#2,415/3,111 Sec#160/206 |